Gilead, Verily Launch Inflammatory Disease Collaboration

Gilead Sciences will partner with Google parent Alphabet’s Verily Life Sciences over the next three years to study immunological and molecular drivers of three inflammatory diseases, the companies said.The value of the collaboration was not announced, though Forbes reported that Gilead had agreed to pay Verily up to $90 million over the three-year period.The companies said they will carry out the first large-scale deployment of Verily’s Immunoscape platform to identify and better und